EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

QT interval prolongation in schizophrenia: A cross-sectional study from a tertiary care center in Raipur

Mishthi Malani, Shrayasi Das, Anirban Saha, Ajay Kumar, Satyajit Singh, Aditya Somani

The Indian Journal of Medical Research · 2025

DOI: 10.25259/ijmr_2221_2024 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift The Indian Journal of Medical Research, 2025. Verfasst von Mishthi Malani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, †All India Institute of Medical Sciences Raipur, Chhattisgarh, India. Hauptthemen laut MEDLINE: Schizophrenia, Antipsychotic Agents, Long QT Syndrome. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives Antipsychotic drugs can cause QT interval prolongation (QTIP), which can lead to life-threatening cardiac manifestations. The objective of this study was to find out the prevalence of QTIP in stable patients of schizophrenia attending the outpatient department/clinic.

Methods

A total of 88 consenting individuals with schizophrenia aged ≥18 yr of either sex (male or female), who were stable on treatment and adherent to the prescribed medications, were included. Patients with any other psychiatric disorder, mental retardation, substance dependence other than caffeine/nicotine, or if they had taken any other drug with moderate to high risk of causing QTIP, were excluded. A 12-lead ECG was recorded. Corrected QT interval was calculated using Fridericia’s and Bazett’s formulae.

Results

QTIP was seen in 3 (3.4%) study participants according to Fridericia’s formula and in 6 (6.8%) study participants according to Bazett’s formula. The recorded demographic, anthropometric, and clinical/treatment variables did not differ among participants with and without QTIP. Interpretation & conclusions Prevalence of antipsychotic drug-induced QTIP in patients with schizophrenia seems to be low, but it poses a risk to life. Regular screening for additional risk factors and periodic assessment of cardiac rhythm via ECG could help prevent potentially fatal cardiac manifestations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaAntipsychotic AgentsLong QT SyndromeHumansMaleFemaleAdultElectrocardiographyTertiary Care CentersMiddle AgedRisk FactorsCross-Sectional StudiesPrevalence

Stichwörter der Autor:innen

Antipsychotic drugsECGQT interval prolongationSchizophreniaTorsades de Pointespatient safety

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Department of Cardiology, †All India Institute of Medical Sciences Raipur, Chhattisgarh, India.
  • Department of Psychiatry, All India Institute of Medical Sciences Raipur, Chhattisgarh, India.

Zitieren

APA

Malani, M., Das, S., Saha, A., Kumar, A., Singh, S., & Somani, A. (2025). QT interval prolongation in schizophrenia: A cross-sectional study from a tertiary care center in Raipur. The Indian Journal of Medical Research. https://doi.org/10.25259/ijmr_2221_2024

Vancouver

Malani M, Das S, Saha A, Kumar A, Singh S, Somani A. QT interval prolongation in schizophrenia: A cross-sectional study from a tertiary care center in Raipur. The Indian Journal of Medical Research. 2025. doi:10.25259/ijmr_2221_2024

BibTeX
@article{Malani2025,
  author = {Malani, Mishthi and Das, Shrayasi and Saha, Anirban and Kumar, Ajay and Singh, Satyajit and Somani, Aditya},
  title = {QT interval prolongation in schizophrenia: A cross-sectional study from a tertiary care center in Raipur},
  journal = {The Indian Journal of Medical Research},
  year = {2025},
  doi = {10.25259/ijmr_2221_2024}
}
Kostenlos starten →